Skip to main content

Bull Capsules, Chao Jimengnan Tablets by Nutra Labs: Recall - Undeclared Drug Ingredients

Audience: Consumer

[Posted 12/01/2017]

ISSUE: Nutra Labs Inc. is voluntarily recalling lots sold by their firm of the male enhancement supplements Bull 1800 mg Capsules with the production date of 05/08/2016, and Chao Jimengnan 150 mg Tablets with Lot # 20151018 to the consumer level. FDA analysis found the products to be tainted with sildenafil, 0.026mg/capsule for Bull, and 70.46mg/tablet for Chao Jimengnan respectively. Sildenafil is the active pharmaceutical ingredient in an FDA approved product used for erectile dysfunction, making Bull capsules and Chao Jimengnan tablets unapproved new drugs.

Use of products with undeclared sildenafil may pose a threat to consumers because the active ingredient may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening. Among the population who are most likely to use these products, adult males who use nitrates for cardiac conditions are the most at risk from these products.

BACKGROUND: The products are marketed as dietary supplements for male sexual enhancement and are packaged as follows: Bull – 30 pills per tin, Chao Jimengnan – 4 pills per box. Bull and Chao Jimengnan were distributed Nationwide via internet.

RECOMMENDATION: Nutra Labs Inc. is notifying its customers by e-mail and is arranging for return of all recalled products. Consumers or retailers that have Bull or Chao Jimengnan which is being recalled should stop using and return to PO Box 571, Ellenton FL 34222 ATTN: RETURNED GOODS for a refund.

Consumers with questions regarding this recall can contact Nutra Labs Inc. at 941-800-2883 or spanishflycoteam@gmail.com M-F 9am-3pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

[11/30/2017 - Press Release - Nutra Labs ]
 

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.